Board of Directors

Stéphane, our Chief Innovation Officer and CTO, invented the Zymtronix core technology and remains the science and engineering lead of the company. His research at Cornell has been focused on microbial ecology, microbial and enzymatic activities, and nano-biotechnology methods to develop bioconversion processes for sustainable and renewable energy and products. He holds an MSc in Soil Science, Microbial Ecology, and Molecular Biology from the University Henri Poincare (Nancy, France). During his PhD, he studied plant-microbe interactions and dynamics applied to the conversion and biodegradation of toxic Polycyclic Aromatic Hydrocarbon (PAH).

Adam joined the Zymtronix Board of Directors in 2020, after almost 30 years with Novozymes where he was President for North America until November 2019. He started with Novozymes in 1991, holding numerous roles from Recovery Engineer, Supply Chain Director for the Americas, Global Capacity Planning and North America leadership. Holding a bachelor in Chemical Engineering from the University of Arkansas, his global expertise in enzyme innovation, markets, production, sales, and logistics is unrivaled and will be instrumental in the next phase of growth of Zymtronix.

Thomas Videbaek spent the last 13 years on the executive team at Novozymes, the world leader in industrial enzymes. Most recently, he was Executive Vice President (EVP) of Corporate Strategy & Business Transformation at Novozymes. He has led initiatives that created several new business areas, including the microbial area of bio-agriculture, as well as building the global supply chain operations. He holds a Bachelor in Business Administration from the Copenhagen Business School, and a PhD and MSc from the Technical University of Denmark in Nutrition and Biochemistry.

Rob has been a member of the Board of Directors since 2015. His leadership experience in successfully building and transforming businesses around the world includes more than two decades in senior executive roles, devoted to the formulation and implementation of strategy, to leading and coaching the development of organizations, and to leading their effective globalization. He was educated at Cornell University where he earned a BSc in Engineering and Applied Physics and an MBA. Selected for a scholarship in the Louvain–Cornell exchange program, he also earned a MSc in Applied Economics from Catholic University of Louvain, Belgium.

Michael joined the Board of Directors upon retiring from his position as CTO at Tate & Lyle. During his tenure at Tate & Lyle, he provided innovative solutions to complex strategic and tactical issues and successfully commercialized award winning, relevant new products. He has 30+ years of business and scientific leadership matching emerging technologies with customer insights and developing leading-edge products from discovery to commercialization. He also collaborated with Innovation Leadership to develop extraordinary talent into highly productive teams.

Wayne has served as a legal advisor to Zymtronix and its affiliates since April 2020. He serves as an Executive in Residence with the McGovern Family Center for Ventures in the Life Sciences for Cornell University at both the Ithaca and New York City campuses. Since February of 2014 he has been in solo private legal practice, and previously served as Vice President, General Counsel and Secretary at Novartis Finance Corporation from January 1997 until January 2014. He has also served in a variety of legal positions both with Novartis Corporation and affiliates, Sandoz Corporation, its predecessor, and with other companies and law firms since August 1975. He has been a member of the New York Bar since January 26, 1976.